TNFRSF11A and Arthritis: Signaling through those pathways has been reported to occur during normal chondrocyte differentiation or OA development in arthritis models, whereas the RANKL-RANK pathway was also proposed as a target for treatment of OA [16,32-35,40,41,46,56-58].